(Q40749755)

23 September 2017

A double-blind study of Prazepam versus placebo in single daily doses in the treatment of anxiety (English)

1 reference

https://api.crossref.org/works/10.1016/0010-440X(77)90058-X

14 March 2023

0 references

H. L. Goldberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319941

14 March 2023

R. J. Finnerty

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319941

14 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=319941

14 March 2023

publication date

1 March 1977

1 reference

full work available at URL

23 September 2017

https://api.elsevier.com/content/article/PII:0010440X7790058X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0010-440X(77)90058-X

https://api.elsevier.com/content/article/PII:0010440X7790058X?httpAccept=text/plain

14 March 2023

1 reference

https://api.crossref.org/works/10.1016/0010-440X(77)90058-X

14 March 2023

published in

Comprehensive Psychiatry

1 reference

23 September 2017

18

1 reference

23 September 2017

147-155

1 reference

23 September 2017

2

1 reference

Prazepam metabolism after chronic administration to humans

23 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0010-440X(77)90058-X

Prazepam in anxiety: a controlled clinical trial

14 March 2023

5

1 reference

https://api.crossref.org/works/10.1016/0010-440X(77)90058-X

The assessment of anxiety states by rating

14 March 2023

6

1 reference

https://api.crossref.org/works/10.1016/0010-440X(77)90058-X

AN ANALYSIS OF MOOD IN NEUROTICS.

14 March 2023

8

1 reference

https://api.crossref.org/works/10.1016/0010-440X(77)90058-X

14 March 2023

Identifiers

1 reference

23 September 2017

1 reference